2019 BioHealth Capital Region Forum

Top 3 by 2023

Miss the 2019 BioHealth Capital Region Forum?

 

20% of the top influencers worldwide in vaccine development

 

World-class tech + big data + biotech + White House Precision Medicine Initiative = new frontiers in patient-centered medicine

1
1

MD | DC | VA

Our Goal: To become a Top 3 BioHealth Hub by 2023.

We are the research engine for the nation and the world. A lifeblood of support for taking new medicines to market. A place where health policymakers and patient advocates seek a better way forward. A home to the established and the startup, pioneering big ideas for human health and hope.

Driving Innovation and Entrepreneurship

  • World–renowned research institutions and universities
  • Influential policymakers and advocacy groups pioneering new health strategies
  • World–leading infectious disease research and vaccine development
  • Fastest growing region for healthcare companies in the U.S.
  • Rated #1 in the nation for science and engineering talent
  • Mission control for the National Cancer Moonshot Initiative

Founding Partners

Viela Bio Receives U.S. FDA Breakthrough Therapy Designation for Inebilizumab for Treatment of Neuromyelitis Optica Spectrum Disorder

April 18, 2019

Gaithersburg, MD—April 18, 2019 – Viela Bio today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for the Company’s anti-CD19 monoclonal antibody inebilizumab, an…

REGENXBIO Appoints Dr. Steve Pakola as Chief Medical Officer

April 17, 2019

ROCKVILLE, Md., April 17, 2019 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®Technology Platform,…

GlaxoSmithKline CEO talks pharmaceutical industry and leadership

April 17, 2019

Emma Walmsley, the CEO of GlaxoSmithKline, discussed the pharmaceutical industry and the role of leadership at the Stanford Medicine Dean’s Lecture on Tuesday. GlaxoSmithKline, commonly known as GSK, is a…

Emergent BioSolutions Announces Interim Results From Phase 2 Study Evaluating CHIKV-VLP, Chikungunya Virus Vaccine Candidate

April 16, 2019

GAITHERSBURG, Md., April 16, 2019 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced results from the interim analysis of its Phase 2 clinical study evaluating the safety and immunogenicity of the company’s chikungunya…

Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion

April 15, 2019

Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare, positioning Catalent for accelerated long-term growth SOMERSET, N.J. and BALTIMORE, M.D. – April 15, 2019 – Catalent,…

Richmond Times-Dispatch: Changes underway at biotech park in downtown Richmond including plans to hire a new president and CEO

April 12, 2019

Carrie Roth is president and CEO of the Virginia Bio+Tech Park and of Activation Capital. The park’s board is seeking a new president and CEO and Roth would stay as…